Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Oct;51(10):1432-7.
doi: 10.1007/s00120-012-2969-4.

[Extracorporeal magnetic innervation: a non-invasive therapy for urinary incontinence?]

[Article in German]
Affiliations
Clinical Trial

[Extracorporeal magnetic innervation: a non-invasive therapy for urinary incontinence?]

[Article in German]
J Wöllner et al. Urologe A. 2012 Oct.

Abstract

Objective: Extracorporeal magnetic innervation (ExMI) is a non-invasive therapy for treatment of urinary incontinence (UI). The aim of the current study was to evaluate the efficacy of ExMI in a prospective case series.

Patients and methods: Over a period of 1.5 years 63 consecutive patients with a clinically and urodynamically confirmed diagnosis of urinary incontinence were enrolled. All patients requested an additional non-surgical therapy option and the ExMI system (Neo control™, Kitalpha, USA) was used. The therapy consisted of 12 treatment sessions two to three times a week. Primary outcome parameter was reduction of the number of pads per 24 h and secondary outcome parameters were patient satisfaction, adverse events and duration of the therapeutic effect.

Results: A total of 63 patients (57 male and 6 female), mean age 68±7.1 years were recruited. After completion a significant (p=0.001) reduction of the number of pads used per 24 h was observed (from 5.4±3.7 to 2.7±2.5) which persisted after a median follow-up of 12.5 months (2.3±2.2 pads per 24 h). Also patients suffering from UI after prostatectomy revealed a significant (p=0.001) reduction in the number of pads from 4.8±2.9 to 2.6±2.6 with persistence at 2.5±2.5 at follow-up. Transient, self-limiting perineal pain in three patients was the only reported side effect.

Conclusions: The ExMI procedure is an additional non-invasive therapy option for patients with urinary incontinence. However, sham-controlled studies are required to corroborate the therapy effect.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur Urol. 2011 Jan;59(1):148-54 - PubMed
    1. J Urol. 1997 Dec;158(6):2127-31 - PubMed
    1. J Urol. 2010 Nov;184(5):2007-12 - PubMed
    1. BJU Int. 2006 May;97(5):1035-8 - PubMed
    1. Am J Obstet Gynecol. 2002 Jul;187(1):40-8 - PubMed

LinkOut - more resources